Table 2.
Primary treatments and death rates among matched ProtecT cases and Anglia Cancer Network (ACN) controls
| Treatment | Matched ProtecT cases |
Matched ACN controls |
||||
|---|---|---|---|---|---|---|
| N | Deaths, n (%) |
n | Deaths, n (%) |
|||
| PCS | AC | PCS | AC | |||
| RP | 47 | 1 (4) | 2 (4) | 150 | 5 (3) | 12 (8) |
| RT + ADT a | 200 | 11 (6) | 31 (16) | 127 | 6 (5) | 20 (16) |
| Nonradical b | 105 | 19 (18) | 37 (35) | 114 | 51 (45) | 68 (60) |
| Unknown | 49 | 6 (12) | 19 (38) | 10 | 1 (10) | 3 (3) |
| Total | 401 | 37 (9) | 89 (22) | 401 | 63 (16) | 103 (26) |
RP = radical prostatectomy; ADT = androgen deprivation therapy; PCS = prostate cancer–specific; AC = all causes.
a
Adjuvant ADT was given in combination with radical radiotherapy in 93% of ProtecT cases and 88% of ACN controls.
b
Nonradical treatment includes primary ADT, palliative chemotherapy, palliative radiotherapy, and monitoring.